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Enhanced Detection of Thromboemboli With the Use of Targeted
Microbubbles
Martin MJ, Chung EML, Goodall AH, et al. Stroke 2007;38:2726-2732.
Conclusion: Transcranial Doppler (TCD) detection of circulating
microemboli can be improved by injection of appropriately targeted micro-
bubbles.
Summary: Some ultrasound contrast agents adhere selectively to spe-
cific pathologic materials, such as plaque or thrombus. Targeting specific
pathologic materials for adherence by microbubbles may allow TCD to
distinguish different types of microembolic material. In this study, the
authors sought to determine whether TCD detection of circulating throm-
bus emboli could be enhanced by targeted microbubbles.
A technique of binding microbubbles to the surface of thrombus was
developed. Binding was confirmed by scanning electron microscopy. Using
an in vitro pulsatile flow model, control and targeted microbubbles were
introduced to thrombus. Thrombus and tissue mimicking material were
then circulated under pulsatile-flow conditions using the model. TCD was
used to detect embolic symbols before and after induction of the micro-
bubbles.
TCD signal intensities were enhanced by the targeted microbubbles up
to 13 dB.Microbubbles were observed to bindmoving thrombus even when
injected in low concentrations (approximately 36 bubbles per 100 mL). The
microbubbles were retained on the thrombus under pulsatile-flow condi-
tions. TCD signal intensity was not enhanced by similar size pieces of tissue
mimicking material not enhanced by injection of targeted microbubbles.
Comment: Targeted microbubble enhancement of TCD emboli de-
tection may allow determination of what TCD really detects during manip-
ulation of the carotid bifurcation. It may eventually be possible to design
targeted therapies to prevent embolization of specific materials.
Serious Lower Extremity Venous Injury Management With Ligation:
Prospective Overview of 63 Patients
Kurtoglu M, Nrynar H, Taviloglu K, et al. American Surgeon 2007;1039-
1043.
Conclusions: Venous ligation for severe venous injury results in no
significant sequelae of chronic venous insufficiency and has no detrimental
effect on associated arterial repair.
Summary: It is recommended that repair of major venous injury be
performed when feasible. However, primary repair may be impossible if
there is extensive disruption of the vein or in an unstable patient. In such
cases, ligation of the venous injury is recommended. The authors investi-
gated the effects of venous ligation of major veins in the lower extremities
when the vein was extensively lacerated from a traumatic injury. Between
January 2001 and April 2004, there were 63 patients with grade 3 and 4
venous injuries treated with ligation who were then observed prospectively.
Patients had venous ultrasound performed on the 5th day postoperatively
prior to discharge and at 3 months to assess for the presence of deep venous
thrombosis (DVT) and patency of any associated arterial repair. Patients
with DVT were treated with sodium warfarin for three months with a target
international normalized ratio of 2.0-3.0. Patients were also treated with
Class II compression stockings for 1 year. Follow-up occurred at 1, 3, 6, and
12 months and at 6 month intervals thereafter.
Fifty of the patients (79.4%) had combined arterial and venous injury.
Pure venous injuries were present in 13 patients (20.6%). DVT developed in
49 patients (77.7%). The DVT was postoperative in 37 patients (58.7%) and
developed late in 12 patients (19%). There were 3 arterial restenoses and one
pseudoaneurysm of the superficial femoral artery observed. Five patients
underwent prophylactic fasciotomy and 2 patients had late fasciotomy for
compartment syndrome. Postoperative edema was present in 56 (88.8%) of
the patients and wound infection occurred in 19 patients (30.1%) with
18/19 wound infections being superficial. There were 2 amputations. One
patient died as a result of hemorrhagic shock. At 18 months, 25 patients
were classified according to the CEAP classification. Three legs were CEAP
class 0, 7 legs CEAP class 2, and 8 legs CEAP class 3. There were no
instances of severe postthrombotic syndrome.
Comment: The article suggests it is not necessary to repair severe
lower extremity venous injuries. The data is restricted to patients that had
essentially unreconstructable venous injuries. Only about 40% of the
patients were available for follow-up to assess for possible postthrom-
botic syndrome. Cleary the data allow one to conclude that ligation of a
severe venous injury in a lower extremities is safe. There are too few
patients and too limited follow-up to justify a conclusion that postthrom-
botic syndrome is not a problem following ligation of major lower
extremity veins for trauma.
Effect of aMultifactorial Intervention onMortality in Type II Diabetes
Gaede P, Lund-Andersen H, Parving H-H, et al. N Engl J Med 2008;58:
580-91.
Conclusion: Death rates from cardiovascular causes can be reduced in
patients with Type II diabetes with use of behavior modification and
intensive intervention with multiple drug combinations.
Summary: It is known that risk of non-fatal cardiovascular disease
among patients with type II diabetes mellitus and micro-albuminuria can be
reduced using multi-factorial interventions that include tight glucose con-
trol, renin-angiotensin system blockers, lipid lowering agents, and aspirin. In
this study the authors evaluated whether such an approach could also reduce
deaths from cardiovascular etiologies and all cause mortality. Patients in this
study were derived from the Steno-T study. There were 160 caucasian
Danish patients with type II diabetes and persistent micro-albuminuria.
They were randomly assigned to receive either conventional multi-factorial
treatment or intensified target-driven therapy involving a combination of
medicines and behavior modification. In the intensive group, target guide-
lines included a glycosurated hemoglobin level of less than 6.5%, a fasting
serum total cholesterol level of less than 175 mg/dl, a fasting serum
triglyceride level of less than 150 mg/dl and systolic blood pressures 130
mmHg and diastolic pressures80 mmHg. Patients also received daily low
dose aspirin.
The trial ran through 2001. By that time 27 patients had died. Three
additional patients withdrew before the end of the trial examinations in
2001. Mean treatment period for either intensive or conventional therapy
was 7.8 years. Patients were subsequently followed for a mean of 5.5 years
until December 31, 2006. The primary end-point at 13.3 years of follow-up
was timed to death from any cause.
During the the study, 24 patients in the intensive therapy group died,
and 40 in the conventional therapy group died (HR 0.54; 95%CI 0.32 to
0.89, P  0.02). Patients having intensive therapy had a lower risk of death
from cardiovascular causes (HR 0.43; 95% CI 0.19 to 0.94; P  0.04).
Intensive therapy patients also had a lower risk of cardiovascular events (HR
0.42; 95%CI, 0.25 to 0.67; P  0.001). Six patients in the conventional
therapy group and one patient in the intensive therapy group progressed to
end stage renal disease (P  0.04).
Comment: The study was not designed to identify which risk factor
modification resulted in the greatest benefit in patients with type II diabetes.
Based on a sub-analysis, however, the authors concluded the statins and
anti-hypertensive drugs likely had the largest effect in reducing cardiovascu-
lar risk with hypoglycemic agents and aspirin the next most important
medications.
Analysis of Expansion Patterns in 4 to 4.9 cm Abdominal Aortic
Aneurysms
Dde Ceniga MV, Gomez R, Estallo L, et al. Annals of Vascular Surgery
2008;22:37-44.
Conclusion: Growth of 4-4.9 cm abdominal aortic aneurysms (AAA)
is mostly irregular and unpredictable without modifiable risk factors to
influence expansion pattern. An eccentric distribution of thrombus within
the aneurysm may be associated with continuous aneurysm expansion.
Summary: Most vascular surgeons have observed AAAs grow unpre-
dictably. The authors thought to quantify growth patterns in 4 to 4.9 cm
infrarenal AAA’s. This was an observational, longitudinal, prospective study.
Patients with 4 to 4.9 cm abdominal aortic aneurysms were followed every
six months with abdominal computed tomographic (CT) scans. The authors
defined aneurysm growth as an increase in aortic diameter2 mm from one
surveillance period to the next. In patients with three or more CT scans the
authors characterized aneurysm expansion as either continuous or discon-
tinuous. A discontinuous growth pattern included at least one period of
non-growth (2 mm over six months). Cardiovascular risk factors were also
correlated with AAA anatomic characteristics and growth.
There were 195 patients in the study, 94% men, mean age 71  8.3
years. Age range was 50 to 90. Follow up occurred for 50  36.4 months
(6.5 to 193.7 months). A discontinuous growth pattern was noted in
88.5% of the AAAs and a continuous growth pattern in 11.5%. In
aneurysms that had continuous expansion, mean expansion rate was greater
than those aneurysms with a discontinuous growth pattern (7.92  3.74
mm vs. 2.74 2.94 mm per year, P 0.0001). No patient co-morbidity or
1371
